Funding Rounds
Haya Therapeutics

Haya Therapeutics Series D Round, September 2024

Haya Therapeutics

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $1000.00M

Raised Date: 2024-09-04

Investors